• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇前药使谷胱甘肽耗竭以增强癌症治疗。

Paclitaxel Prodrug Enables Glutathione Depletion to Boost Cancer Treatment.

机构信息

Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China.

School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, P. R. China.

出版信息

ACS Nano. 2024 Oct 1;18(39):26690-26703. doi: 10.1021/acsnano.4c06399. Epub 2024 Sep 20.

DOI:10.1021/acsnano.4c06399
PMID:39303096
Abstract

Herein, we constructed a paclitaxel (PTX) prodrug (PA) by conjugating PTX with acrylic acid as a cysteine-depleting agent. The as-synthesized PA can assemble with diacylphosphatidylethanolamine-PEG to form stable nanoparticles (PA NPs). After endocytosis into cells, PA NPs can specifically react with cysteine and trigger release of PTX for chemotherapy. On the other hand, the depletion of cysteine can greatly downregulate the intracellular content of glutathione and lead to oxidative stress outburst-provoking ferroptosis. The released PTX can elicit antitumor immune response by inducing immunogenic cell death, thus promoting dendritic cells maturation and cascaded cytotoxic T lymphocytes activation, which not only produces a robust immunotherapy effect but also synergizes the ferroptosis therapy by inhibiting cysteine transport via the release of interferon-γ in the activated immune system. As a result, PA NPs exhibit favorable in vitro and in vivo antitumor performance with reduced systemic toxicity. Our work highlights the potential of simple molecular design of prodrugs for enhancing the therapeutic efficacy toward malignant cancer.

摘要

在这里,我们通过将紫杉醇(PTX)与丙烯酸连接,构建了一种作为半胱氨酸耗竭剂的紫杉醇前药(PA)。合成的 PA 可以与二酰基磷脂酰乙醇胺-PEG 组装形成稳定的纳米颗粒(PA NPs)。PA NPs 被细胞内吞后,可以特异性地与半胱氨酸反应,并触发 PTX 的释放以进行化疗。另一方面,半胱氨酸的耗竭会大大降低细胞内谷胱甘肽的含量,导致氧化应激爆发引发铁死亡。释放的 PTX 通过诱导免疫原性细胞死亡引发抗肿瘤免疫反应,从而促进树突状细胞成熟和级联细胞毒性 T 淋巴细胞激活,不仅产生强大的免疫治疗效果,还通过在激活的免疫系统中释放干扰素-γ来抑制半胱氨酸转运,与铁死亡治疗协同增效。结果,PA NPs 表现出良好的体外和体内抗肿瘤性能,同时降低了全身毒性。我们的工作强调了通过简单的前药分子设计来提高恶性癌症治疗效果的潜力。

相似文献

1
Paclitaxel Prodrug Enables Glutathione Depletion to Boost Cancer Treatment.紫杉醇前药使谷胱甘肽耗竭以增强癌症治疗。
ACS Nano. 2024 Oct 1;18(39):26690-26703. doi: 10.1021/acsnano.4c06399. Epub 2024 Sep 20.
2
Ferrocene-Conjugated Paclitaxel Prodrug for Combined Chemo-Ferroptosis Therapy of Cancer.二茂铁-紫杉醇前药用于癌症的联合化疗-铁死亡治疗。
ACS Appl Mater Interfaces. 2024 Sep 11;16(36):47325-47336. doi: 10.1021/acsami.4c11418. Epub 2024 Aug 27.
3
Enhanced in vivo Stability and Antitumor Efficacy of PEGylated Liposomes of Paclitaxel Palmitate Prodrug.聚乙二醇化棕榈酸紫杉醇前药脂质体的体内稳定性和抗肿瘤功效增强。
Int J Nanomedicine. 2024 Nov 9;19:11539-11560. doi: 10.2147/IJN.S488369. eCollection 2024.
4
Paclitaxel prodrug nanoparticles boost antitumor efficacy via hitchhiking of human serum albumin.紫杉醇前药纳米粒通过人血清白蛋白的搭便车提高抗肿瘤疗效。
J Colloid Interface Sci. 2025 Feb;679(Pt B):144-154. doi: 10.1016/j.jcis.2024.10.075. Epub 2024 Oct 16.
5
Sequential pH/GSH-responsive stealth nanoparticles for co-delivery of anti-PD-1 antibody and paclitaxel to enhance chemoimmunotherapy of lung cancer.用于共递送抗PD-1抗体和紫杉醇以增强肺癌化学免疫疗法的顺序pH/谷胱甘肽响应性隐形纳米颗粒。
Eur J Med Chem. 2025 Mar 5;285:117273. doi: 10.1016/j.ejmech.2025.117273. Epub 2025 Jan 10.
6
Tumor-Associated Neutrophil Extracellular Traps Regulating Nanocarrier-Enhanced Inhibition of Malignant Tumor Growth and Distant Metastasis.肿瘤相关中性粒细胞胞外诱捕网调控纳米载体增强抑制恶性肿瘤生长和远处转移。
ACS Appl Mater Interfaces. 2021 Dec 22;13(50):59683-59694. doi: 10.1021/acsami.1c18660. Epub 2021 Dec 13.
7
Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer.肺部递送活性氧/谷胱甘肽响应性紫杉醇二聚体纳米颗粒提高转移性肺癌的治疗指数。
ACS Appl Mater Interfaces. 2021 Dec 8;13(48):56858-56872. doi: 10.1021/acsami.1c16351. Epub 2021 Nov 20.
8
Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.负载高剂量紫杉醇 - 硅酸盐前药的纳米颗粒:制剂、药物释放及抗癌疗效
Mol Pharm. 2015 Dec 7;12(12):4329-35. doi: 10.1021/acs.molpharmaceut.5b00530. Epub 2015 Nov 4.
9
Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.乙酰化连接的紫杉醇前药胶束纳米粒作为一种通用且有效的癌症治疗平台。
Biomacromolecules. 2013 Aug 12;14(8):2772-80. doi: 10.1021/bm400615n. Epub 2013 Jul 1.
10
Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.用于肿瘤特异性递送紫杉醇的明确定义的氧化还原敏感型聚乙二醇-紫杉醇前药缀合物,使用奥曲肽进行肿瘤靶向。
Mol Pharm. 2015 Aug 3;12(8):3020-31. doi: 10.1021/acs.molpharmaceut.5b00280. Epub 2015 Jun 30.

引用本文的文献

1
Nanomedicine initiates ferroptosis for enhanced lung cancer therapy.纳米医学引发铁死亡以增强肺癌治疗效果。
Drug Deliv. 2025 Dec;32(1):2527752. doi: 10.1080/10717544.2025.2527752. Epub 2025 Jul 5.
2
Harnessing nanoprodrugs to enhance cancer immunotherapy: overcoming barriers to precision treatment.利用纳米前药增强癌症免疫疗法:克服精准治疗的障碍。
Mater Today Bio. 2025 May 31;32:101933. doi: 10.1016/j.mtbio.2025.101933. eCollection 2025 Jun.
3
Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance.
创新纳米药物递送:靶向肿瘤微环境以克服耐药性。
Pharmaceutics. 2024 Dec 3;16(12):1549. doi: 10.3390/pharmaceutics16121549.